Download Complete RFA Announcement in PDF format (229KB)

EXECUTIVE SUMMARY:
The Substance Abuse and Mental Health Services Administration (SAMHSA), Center
for Substance Abuse Treatment (CSAT) is accepting applications for fiscal year (FY)
2013 Cooperative Agreement for the Physician Clinical Support System - Medication
Assisted Treatment grant. The purpose of this program is to build upon the current
SAMHSA-funded Physician Clinical Support System – Buprenorphine (PCSS-B) , a
national mentoring network offering support (clinical updates, evidence-based outcomes
and training) by expanding the focus on buprenorphine to include the other two FDA
approved medications for the treatment of opioid addiction, methadone and extended
release naltrexone and increasing the amount of training for office based physicians and
opioid treatment program medical professionals. The program will provide up to date
and evidence-based information to support training of health professionals and to
address complex issues of addiction.
Funding Opportunity Title
Funding Opportunity Number:
Cooperative Agreement for the Physician
Clinical Support System - Medication Assisted
Treatment
TI-13-003
Due Date for Applications: April 1, 2013
Anticipated Total Available Funding: $1 million
Estimated Number of Awards:
Estimated Award Amount:
Cost Sharing/Match Required
Length of Project Period:
Eligible Applicants:
One
Up to $1 million
No
Up to three years
Eligibility is limited to the national professional
medical organizations authorized by the Drug
Addiction Treatment Act of 2000 (DATA) to
carry out the training of physicians desiring to
prescribe and/or dispense FDA approved
schedule III products for the treatment of
addictive disorders. These are the American
Society of Addiction Medicine, the American
Academy of Addiction Psychiatry, the
American Medical Association, the American
Osteopathic Association, and the American
Psychiatric Association.
4